← Eichor
Condition: Visual Field Defect Homonymous Bilateral Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Visual Field Defect Homonymous Bilateral

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Neuromodulation Through Multisensory Stimulation for Visual Field Deficits in the Subacute Stage of Disease
NA · 1 location(s) · Istituto Auxologico Italiano · NCT07358832
Biofeedback for Hemianopia Vision Rehabilitation
NA · 1 location(s) · University Health Network, Toronto · NCT05397873
Mechanisms of Visual Restoration After Occipital Stroke
Phase N/A · 1 location(s) · University of Rochester · NCT07134777
Improving Visual Field Deficits With Noninvasive Brain Stimulation
NA · 1 location(s) · Beth Israel Deaconess Medical Center · NCT05085210
Effect of Visual Retraining After Stroke
NA · 1 location(s) · University of Rochester · NCT06121219
Vision Loss Impact on Navigation in Virtual Reality
NA · 1 location(s) · University of Rochester · NCT06047717
Neurofeedback-based Visual Restoration Therapy
NA · 2 location(s) · Adrian Guggisberg · NCT07237412
Home-based Vision Rehabilitation Guided by Brain Imaging
NA · 1 location(s) · Georgetown University · NCT07635329
Feasibility Tests for Various Prism Configurations for Visual Field Loss
NA · 1 location(s) · Massachusetts Eye and Ear Infirmary · NCT04424979
PAVE (Parallactic Visual-Field Enhancement) System for Treatment of Chronic Visual Field Loss Due to Stroke, Traumatic B
NA · 2 location(s) · NeuroAEye LLC · NCT07185971
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.